bmiMD GLP-1 prices
Compounded semaglutide and tirzepatide on 1-, 3-, 6- and 12-month plans with the telehealth visit and shipping included, the same price at every dose, in all 50 states. bmiMD has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide $159/mo; Compounded tirzepatide $249/mo. Compounded products are not FDA-approved. Plan terms, fees and the check date are listed with each quote.
Search by medication, provider or treatment goal. Examples follow.
2 offers · US self-pay · 0 maintenance quotes
This order ignores commission. Partner links may earn us a referral fee.
- Maintenance priceView offer
No separate dose price verified
Price conditions & source
Advertised price: 1-month plan; $149/mo on 3 months ($447), $129/mo on 6 months ($774), $119/mo on 12 months ($1,428), each billed for the period; telehealth visit and shipping included; same price at every dose
At-home injection, in all 50 states; FSA and HSA accepted. bmiMD's semaglutide shopping page, which its help center links as its pricing, shows $129 a month (1 month) down to $99 (12 months) through coupon links. A microdose plan has the same prices as the standard plan. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source - Maintenance priceView offer
No separate dose price verified
Price conditions & source
Advertised price: 1-month plan; $229/mo on 3 months ($687), $189/mo on 6 months ($1,134), $179/mo on 12 months ($2,148), each billed for the period; telehealth visit and shipping included; same price at every dose
At-home injection, in all 50 states; FSA and HSA accepted. A microdose plan has the same prices as the standard plan. Compounded; not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
Some outbound links on GLPcompare are referral links. If you sign up or buy through one, we may earn a commission at no extra cost to you. It never changes the price you pay or the underlying data. Partner status and commission rates contribute to offer and provider value scores and can change their order. Every partner is labeled. Value scores are not medical recommendations; a higher-ranked offer is not necessarily the lowest price or the right product for you.
bmiMD GLP-1 cost: common questions
How much does semaglutide cost through bmiMD?
Compounded semaglutide: $159/mo (1-month plan; $149/mo on 3 months ($447), $129/mo on 6 months ($774), $119/mo on 12 months ($1,428), each billed for the period; telehealth visit and shipping included; same price at every dose). Checked Oct 16, 2026; each quote links its source in the table. Compounded semaglutide is not an FDA-approved product.
How much does tirzepatide cost through bmiMD?
Compounded tirzepatide: $249/mo (1-month plan; $229/mo on 3 months ($687), $189/mo on 6 months ($1,134), $179/mo on 12 months ($2,148), each billed for the period; telehealth visit and shipping included; same price at every dose). Checked Oct 16, 2026; each quote links its source in the table. Compounded tirzepatide is not an FDA-approved product.
Does bmiMD offer FDA-approved GLP-1 medication or compounded versions?
The bmiMD offers tracked here are compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
When were bmiMD prices last checked?
Each quote carries its own check date and links the page it was read from: Oct 16, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.